209 related articles for article (PubMed ID: 26068418)
21. Loss of MTSS1 results in increased metastatic potential in pancreatic cancer.
Zeleniak AE; Huang W; Brinkman MK; Fishel ML; Hill R
Oncotarget; 2017 Mar; 8(10):16473-16487. PubMed ID: 28146435
[TBL] [Abstract][Full Text] [Related]
22. Manganese superoxide dismutase expression is negatively associated with microRNA-301a in human pancreatic ductal adenocarcinoma.
Pandit H; Zhang W; Li Y; Agle S; Li X; Li SP; Cui G; Li Y; Martin RC
Cancer Gene Ther; 2015 Oct; 22(10):481-6. PubMed ID: 26384137
[TBL] [Abstract][Full Text] [Related]
23. Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma.
Penchev VR; Chang YT; Begum A; Ewachiw T; Gocke C; Li J; McMillan RH; Wang Q; Anders R; Marchionni L; Maitra A; Uren A; Rasheed Z; Matsui W
Mol Cancer Res; 2019 Apr; 17(4):929-936. PubMed ID: 30655325
[TBL] [Abstract][Full Text] [Related]
24. Early Loss of Forkhead Transcription Factor, O Subgroup, Member 1 Protein in the Development of Pancreatic Ductal Adenocarcinoma.
Al-Zoughbi W; Schauer S; Pichler M; Hoefler G
Pathobiology; 2018; 85(5-6):342-347. PubMed ID: 30227407
[TBL] [Abstract][Full Text] [Related]
25. KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis.
Yuan P; He XH; Rong YF; Cao J; Li Y; Hu YP; Liu Y; Li D; Lou W; Liu MF
Cancer Res; 2017 Jan; 77(1):100-111. PubMed ID: 27793842
[TBL] [Abstract][Full Text] [Related]
26. CircFOXK2 Promotes Growth and Metastasis of Pancreatic Ductal Adenocarcinoma by Complexing with RNA-Binding Proteins and Sponging MiR-942.
Wong CH; Lou UK; Li Y; Chan SL; Tong JH; To KF; Chen Y
Cancer Res; 2020 Jun; 80(11):2138-2149. PubMed ID: 32217695
[TBL] [Abstract][Full Text] [Related]
27. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.
Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P
Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271
[TBL] [Abstract][Full Text] [Related]
28. GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma.
Jo JH; Kim SA; Lee JH; Park YR; Kim C; Park SB; Jung DE; Lee HS; Chung MJ; Song SY
BMC Cancer; 2021 Nov; 21(1):1241. PubMed ID: 34794402
[TBL] [Abstract][Full Text] [Related]
29. Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγ(null) (NOG) mice.
Matsuda Y; Yoshimura H; Ueda J; Naito Z; Korc M; Ishiwata T
Am J Pathol; 2014 Mar; 184(3):674-85. PubMed ID: 24412093
[TBL] [Abstract][Full Text] [Related]
30. Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma.
Vizio B; Mauri FA; Prati A; Trivedi P; Giacobino A; Novarino A; Satolli MA; Ciuffreda L; Camandona M; Gasparri G; Bellone G
Oncol Rep; 2012 Jan; 27(1):69-76. PubMed ID: 21922151
[TBL] [Abstract][Full Text] [Related]
31. Bcl3 Couples Cancer Stem Cell Enrichment With Pancreatic Cancer Molecular Subtypes.
Ai J; Wörmann SM; Görgülü K; Vallespinos M; Zagorac S; Alcala S; Wu N; Kabacaoglu D; Berninger A; Navarro D; Kaya-Aksoy E; Ruess DA; Ciecielski KJ; Kowalska M; Demir IE; Ceyhan GO; Heid I; Braren R; Riemann M; Schreiner S; Hofmann S; Kutschke M; Jastroch M; Slotta-Huspenina J; Muckenhuber A; Schlitter AM; Schmid RM; Steiger K; Diakopoulos KN; Lesina M; Sainz B; Algül H
Gastroenterology; 2021 Jul; 161(1):318-332.e9. PubMed ID: 33819482
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic cancer stem cells: features and detection methods.
Ishiwata T; Matsuda Y; Yoshimura H; Sasaki N; Ishiwata S; Ishikawa N; Takubo K; Arai T; Aida J
Pathol Oncol Res; 2018 Oct; 24(4):797-805. PubMed ID: 29948612
[TBL] [Abstract][Full Text] [Related]
33. Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment.
Rausch V; Liu L; Apel A; Rettig T; Gladkich J; Labsch S; Kallifatidis G; Kaczorowski A; Groth A; Gross W; Gebhard MM; Schemmer P; Werner J; Salnikov AV; Zentgraf H; Büchler MW; Herr I
J Pathol; 2012 Jul; 227(3):325-35. PubMed ID: 22262369
[TBL] [Abstract][Full Text] [Related]
34. MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival.
He D; Miao H; Xu Y; Xiong L; Wang Y; Xiang H; Zhang H; Zhang Z
PLoS One; 2014; 9(11):e112930. PubMed ID: 25411783
[TBL] [Abstract][Full Text] [Related]
35. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.
Zhang J; Zhao CY; Zhang SH; Yu DH; Chen Y; Liu QH; Shi M; Ni CR; Zhu MH
Oncol Rep; 2014 Mar; 31(3):1157-64. PubMed ID: 24398877
[TBL] [Abstract][Full Text] [Related]
37. Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies.
Lonardo E; Cioffi M; Sancho P; Crusz S; Heeschen C
J Vis Exp; 2015 Jun; (100):e52801. PubMed ID: 26132091
[TBL] [Abstract][Full Text] [Related]
38. The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma.
Begum A; Ewachiw T; Jung C; Huang A; Norberg KJ; Marchionni L; McMillan R; Penchev V; Rajeshkumar NV; Maitra A; Wood L; Wang C; Wolfgang C; DeJesus-Acosta A; Laheru D; Shapiro IM; Padval M; Pachter JA; Weaver DT; Rasheed ZA; Matsui W
PLoS One; 2017; 12(7):e0180181. PubMed ID: 28692661
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic cancer stem cells: A state or an entity?
Hermann PC; Sainz B
Semin Cancer Biol; 2018 Dec; 53():223-231. PubMed ID: 30130664
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1.
Zhou L; Zhang WG; Wang DS; Tao KS; Song WJ; Dou KF
Oncol Rep; 2014 Oct; 32(4):1734-40. PubMed ID: 25109303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
